Notes
Meso Finance IDO 社区轮正式开启!5 月 22 日确定上线 CEX
备受瞩目的 @Meso_Finance IDO 社区轮今日正式开启!作为 @Aptos 生态头部借贷协议,Meso Finance 当前锁定总价值(TVL)达 6500 万美元,此次 IDO 为早期支持者提供了抢占先机的绝佳机会。
👉 立即参与 Meso Finance IDO:https://t.co/3vcJddDtw5
补充信息:关于 Meso Finance
Meso Finance 是 Aptos 链上领先的去中心化借贷协议,致力于为用户提供安全、高效的借贷服务。
其核心亮点包括:
强大的生态背书:作为 Aptos 基金会支持的项目,协议稳定性与长期发展得到有力保障,基金会将持续监控市场动态以维护生态稳定。
低流通压力的通证模型:仅 3% 的代币用于空投,且 TGE(代币生成事件)时无团队代币解锁,初期流通量极少,抛售压力显著降低。
用户友好机制:IDO 代币 100% 在 TGE 时解锁,无锁仓期或悬崖条款,同时提供退款政策(上线后 12 小时内可申请),降低参与风险。
行业先发优势:作为 “Aptos DeFi 夏季” 首个重磅项目(后续将有 Echo Protocol、Pact Consortium 等跟进),有望率先吸引资本流入,引领生态热潮。
IDO 关键信息:
时间:5 月 19 日–5 月 21 日
平台:Meso Finance 官网、MoveGPT、Cellana
价格:0.01 USDT
代币分配:500 万枚 $MESO (占总供应量 5%),初始市值(IMC,不含流动性)60 万美元
参与方式:白名单轮 + 先到先得(FCFS)
结语:为何值得关注与参与?
从近期市场趋势看,IDO 概念正强势回归,而 Meso Finance 凭借其扎实的基本面与独特优势,堪称当前最值得参与的项目之一
低风险高潜力:100% 即时解锁与退款政策为投资者提供 “双重保险”,而低初始市值(仅 60 万美元)意味着上行空间巨大,参考同类项目,TGE 后或迎来数倍涨幅。
生态红利窗口:作为 Aptos DeFi 夏季的 “开门红” 项目,$MESO 有望成为资金流入生态的 “第一站”,叠加 5 月 22 日 CEX 上线的确定性,市场情绪与做市商支持将进一步推高代币流动性与价格。
长期价值支撑:协议本身已验证其市场需求(6500 万 TVL),代币经济模型聚焦用户激励与生态扩张,长期持有可共享协议成长收益。

STOCKS ON THE MOVE
Lamb Weston ( $LW): Shares dropped after naming Michael Smith as CEO on Jan 3, following activist investor Jana Partners' push for board changes or a sale. LW cut FY sales forecast to $6.35B-$6.45B from $6.6B-$6.8B after Q2 sales fell 8% to $1.6B; approved $250M buyback.
Lennar Corp. ( $LEN): Q4 revenue down 9.3% to $9.95B, below estimates. New orders dropped 2.7% to 16,895, backlog down 22%. Forecasts Q1 new orders at 17,500-18,000, deliveries at 17,000-17,500.
MillerKnoll Inc. ( $MLKN): Q2 EPS $0.55 vs. $0.56 est., sales up 2.2% to $970.4M. Gross margin fell to 38.8%. Guides Q3 sales $903M-$943M, EPS $0.41-$0.47.
Steelcase ( $SCS): Q3 EPS $0.30 vs. $0.22 est., sales up 2.2% to $794.9M. Q4 guidance EPS $0.20-$0.24, revenue $770M-$795M.
Stanley Black & Decker ( $SWK): Upgraded to Outperform by Mizuho, price target $110, added to top picks.
Tri-Pointe Homes ( $TPH): Announced $250M stock buyback program.
Swiss Watch Exports: November exports down 3.8% to CHF 2.41B, with U.S. as the only top market increasing by 4.7%.
Palantir Technologies ( $PLTR): Extended U.S. Army contract worth up to $618.9M to enhance data operations, continuing data and AI support since 2018.
Block ( $SQ): Upgraded to Outperform by Oppenheimer with a $115 target, citing growth in Square's Gross Payment Volume due to product and sales investments.
Raymond James ( $RJF): November client assets under administration at $1.60T (+3.6% m/m), financial assets under management at $251.7B (+4.4% m/m).
Synchrony ( $SYF): Upgraded to Overweight from Underweight by Morgan Stanley.
Mesoblast ( $MESO): Shares up after FDA approval of Ryoncil for treating GVHD in pediatric patients not responding to steroids.
Prothena ( $PRTA): Phase IIb PADOVA study by Roche on prasinezumab for early Parkinson's missed its primary endpoint after 18 months.
Vertex Pharmaceuticals ( $VRTX): Phase 2 study of suzetrigine in LSR met primary endpoint with significant pain reduction; plans for Phase 3 advancement.
Micron Technology ( $MU): Q1 adj EPS $1.79 vs. $1.76 est., revenue up 84% to $8.71B. Shares fell after hours due to Q2 forecast below expectations: revenue $7.7B-$8.1B vs. $8.99B est., gross margin 37.5%-39.5% vs. 41.3% est., EPS $1.33-$1.53 vs. $1.92 est. FY25 capex about $14B. Memory stocks STX, WDC also dropped.
Accenture ( $ACN): Q1 EPS $3.59 vs. $3.42 est., revenue up 9% to $17.69B vs. $17.15B est. Operating margin at 16.7%. Lowered FY EPS guidance to $12.43-$12.79 from $12.55-$12.91.
Keybanc: Upgraded Okta ( $OKTA) and Fortinet ( $FTNT) to Overweight, downgraded https://t.co/n5rFzz3Pbq (AI) to Underweight.
U.S. Commerce Department: Awarded SK Hynix up to $458M for an advanced chip plant and R&D facility in Indiana for AI.